Nutanix Inc (NASDAQ:NTNX) does about 2.26M shares in volume on a normal day but saw 2293873 shares change hands in the recent trading day. The company now has a market cap of 17.19B USD. Its current market price is $64.17, marking a decrease of -1.76% compared to the previous close of $65.32. The 52 week high reached by this stock is $75.80 whilst the lowest price level in 52 weeks is $43.35. The script in recent trading has seen the stock touch a high of $85 and a low of $72.
Nutanix Inc (NTNX) has a 20-day trading average at $68.92 and the current price is -15.34% off the 52-week high compared with 48.03% distance from its 52-week low. The 50-day simple moving average of the closing price is $65.61 and its 200-day simple moving average is $60.60. If we look at the stock’s price movements over the week, volatility stands at 3.82%, which decreases to 3.51% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 40.81 to suggest the stock is neutral.
11 analysts observing the Nutanix Inc (NTNX) stock have set the 12-month price targets for the company’s shares at between $72 and $85. The consensus objective for the share price is $83.25, suggesting that the stock has a potential upside of 22.92% over the period. The median price target is 18.77% away from the current levels at $79.
FactSet Research has provided data showing that 11 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 9 analysts have rated it as a buy and 2 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on November 13, 2024 when Oppenheimer initiated the stock to “Outperform” and issued a price target of $80. Morgan Stanley upgraded the stock to “Overweight” from Equal-Weight on October 28, 2024 at a price target of $71-$72. Northland Capital downgraded its price target at $71.
The current price level is -6.89%, -2.20%, and 5.89% away from its SMA20, SMA50, and SMA200 respectively, with the NTNX price moving above the 50-day SMA on current market day. Nutanix Inc (NTNX) stock is down -2.79% over the week and -8.72% over the past month. Its price is 34.56% year-to-date and 39.44% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at 0.47 and 1.5 for whole year. Expected sales for next quarter are $594.33M, which analysts say will come at $2.46B for the current fiscal year and next year at $2.86B. In addition, estimates put the company’s current quarterly revenue at an average of $641.76M.
Its 12-month price target is $79. To reach the target analysts have set, the stock logically needs to grow 22.92 percent from here. Of course, the average price target is just what the average analysts believe a stock will be worth in the next 52 weeks, and is only one metric. There are analysts with lower targets than the average, including one bearish Wall Street research firm advocating investors to wait for the price to pull back to $72, given the recent momentum. And then, on the bullish side of things, one analyst is expecting the stock to peak at $85.
Outstanding shares total 267.85M with insiders holding 0.47% of the shares and institutional holders owning 85.40% of the company’s common stock. The forward price to earnings ratio is 34.16. The beta has a value of 1.15. Price to sales ratio is 7.71.
